Advertisement

India

Updated on: Thursday, August 12, 2021, 11:10 PM IST

Union Minister Mansukh Mandaviya meets WHO Chief Scientist Dr Soumya Swaminathan, discusses WHO's approval of Covaxin

Union Health Minister Mansukh Mandaviya met WHO Chief Scientist Dr. Soumya Swaminathan and discussed WHO's the approval of Bharat Biotech's Covaxin. in New Delhi on Thursday | ANI

Union Health Minister Mansukh Mandaviya met WHO Chief Scientist Dr. Soumya Swaminathan and discussed WHO's the approval of Bharat Biotech's Covaxin. in New Delhi on Thursday | ANI

Advertisement

New Delhi

Union Health Minister Mansukh Mandaviya on Thursday met World Health Organization (WHO) Chief Scientist Dr Soumya Swaminathan and held a discussion over the world body's approval of Bharat Biotech's Covaxin.

The Hyderabad-based Bharat Biotech manufactured Covid vaccine earlier this month received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.

The approval was received from the National Institute of Pharmacy and Nutrition Hungary certifying the GMP for the manufacture of Covaxin.

With the approval, Bharat Biotech achieved another significant milestone in innovating and manufacturing vaccines at global quality standards and moving forward in the ongoing fight against the Covid pandemic, read a Bharat Biotech statement.

The Indian Council of Medical Research (ICMR) has however revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the country's Covid vaccination programme, conducted on 18 people, has elicited better safety and immunogenicity results.

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Published on: Thursday, August 12, 2021, 11:10 PM IST
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement